Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy: clinical considerations.

S P Scully1

  • 1Division of Orthopaedics, Duke University Medical Center, Durham, NC 27710, USA.

Clinical Orthopaedics and Related Research
|October 20, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracellular matrix-induced transforming growth factor-beta receptor signaling dynamics.

Oncogene·2010
Same author

Decrease in particle-induced osteolysis in obese (ob/ob) mice.

Biomaterials·2004
Same author

Calcific myonecrosis: a unique presentation in the upper extremity.

Skeletal radiology·2004
Same author

Adjuvant chemotherapy for osteosarcoma may not increase survival after neoadjuvant chemotherapy and surgical resection.

Journal of surgical oncology·2001
Same author

The clinical significance of tenascin-C splice variant expression in chondrosarcoma.

Oncology·2001
Same author

Chondrosarcoma of bone: analysis of 108 cases and evaluation for predictors of outcome.

Clinical orthopaedics and related research·2001
Same journal

Impact Microindentation Evaluates Bone Strength, Bone Quality, and Fracture Susceptibility Across Skeletal Sites: A Cadaver Study.

Clinical orthopaedics and related research·2026
Same journal

What Is the Effect of Robot Reduction in Displaced Pelvic Fractures? A Multicenter Randomized Clinical Trial.

Clinical orthopaedics and related research·2026
Same journal

CORR Insights®: Acute or Delayed TKA for Tibial Plateau Fracture? An Observational Study From the Swedish Arthroplasty Register.

Clinical orthopaedics and related research·2026
Same journal

Reply to the Letter to the Editor: Guest Editorial: Recalling a Recall.

Clinical orthopaedics and related research·2026
Same journal

Radial Head Fractures Cluster in the Anterolateral and Anteromedial Quadrants and Do Not Correlate With Coronoid Fracture Types.

Clinical orthopaedics and related research·2026
Same journal

Reduced Cerebellar Activation With Eyes Closed Is Associated With Delayed Peroneal Reaction Time in Patients With Chronic Ankle Instability.

Clinical orthopaedics and related research·2026
See all related articles

Gene therapy trials are advancing, but safety concerns, including fatalities, highlight the need for improved vector delivery systems. Future goals include targeted, regulated gene delivery for better disease treatment.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Medical Research

Background:

  • Gene therapy involves introducing nucleic acids into cells to treat diseases.
  • Over 313 trials with 2000+ patients have been conducted, primarily for cancer and AIDS.
  • Retroviral and adenoviral vectors are commonly used delivery systems.

Purpose of the Study:

  • To review the current status of gene therapy trials.
  • To highlight the evolving understanding of associated risks.
  • To discuss future directions for vector development.

Main Methods:

  • Review of clinical trial data.
  • Analysis of safety reporting in gene therapy.
  • Discussion of vector technology and delivery systems.

Related Experiment Videos

Main Results:

  • Majority of trials are Phase I/II, focusing on cancer and AIDS.
  • A fatality in 1999 underscored underappreciated risks.
  • Concerns exist regarding underreporting of non-fatal adverse events.

Conclusions:

  • Safety evaluation must consider disease severity and alternative treatments.
  • The ultimate goal is targeted, physiologically regulated gene delivery.
  • Significant improvements in delivery systems or novel vectors are required.